Overview

Extension Study of Drisapersen in DMD Subjects

Status:
No longer available

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This is a phase IIIb, multi-centre, open-label extension study in male subjects with DMD who previously have been treated with drisapersen, aiming at assessing the safety and efficacy of drisapersen.

Details

Lead Sponsor:

BioMarin Pharmaceutical